GlassScriptPhysician profile
Cesar A Reyes
NPI 1982620480
$6,670.43
in general payments reported to CMS, 2019-2025
37 companies · $2,480 in 2025
The $2,480 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $259 · 2021: $540 · 2022: $612 · 2023: $548 · 2024: $1,757 · 2025: $2,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $784.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $4,000.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $942.07 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.31 | 2019-2024 | |
| Organon LLC | $138.96 | 2022-2025 | Nexplanon |
| Pfizer INC. | $125.83 | 2022-2024 | |
| Exeltis, USA INC. | $108.99 | 2019-2023 | Slynd |
| Innovation Technologies INC | $82.23 | 2023 | Irrisept |
| Aspira Women'S Health INC | $80.95 | 2021-2022 | |
| Therapeuticsmd, INC. | $71.25 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.65 | 2022 | |
| Lupin INC. | $67.71 | 2019-2020 | |
| Mission Pharmacal Company | $66.41 | 2019-2021 | |
| Coopersurgical, INC. | $59.30 | 2020-2023 | Mara Console |
| Sage Therapeutics, LLC | $52.51 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $47.44 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $44.97 | 2019 | |
| Minerva Surgical, INC | $44.74 | 2021-2022 | |
| Abiomed | $42.01 | 2024 | Impella |
| Sumitomo Pharma America, INC. | $39.52 | 2023 | Myfembree |
| Myovant Sciences INC. | $38.74 | 2021-2022 | |
| Avanos Medical | $36.57 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $34.84 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $32.89 | 2021 | |
| Allergan, INC. | $32.56 | 2020 | |
| Mayne Pharma Commercial LLC | $29.97 | 2025 | |
| Hologic Sales and Service, LLC | $27.47 | 2019-2022 | |
| Evofem Biosciences, INC. | $24.79 | 2021 | |
| Meditrina | $23.86 | 2021 | |
| Daiichi Sankyo INC. | $22.62 | 2021 | |
| Genzyme Corporation | $22.43 | 2023 | |
| Vertical Pharmaceuticals, LLC | $17.42 | 2020 | |
| Agile Therapeutics, INC. | $16.90 | 2021 | |
| Duchesnay USA Incorporated | $15.48 | 2019 | |
| Abbott Laboratories | $15.22 | 2023 | Jot Dx |
| Acessa Health INC. | $14.65 | 2021 | |
| Ascend Therapeutics US, LLC | $14.10 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.